Prostate Cancer: 2020 Year in Review

home / clinical-consult / prostate-cancer-2020-year-in-review

Urology Times spoke with Raoul S. Concepcion, MD, FACS, and Christopher M. Pieczonka, MD, about advances made in the prostate cancer space in 2020.

Recent Content

FDA clears image-guided navigation platform for focal therapy in prostate cancer

Category III CPT code issued for Enhanced Lithotripsy System

When to report 50320 with 49187 for nephrectomy procedures

Daniel D. Joyce, MD, MS, discusses the economics of trimodal therapy in MIBC

Contact Info

2 Commerce Drive
Cranbury, NJ 08512